arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

ACCURAY INC

ARAY
$0.23 ▼ -0.01 (-4.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
15
Health
Poor
Bearish
auto_awesome

Analytical Summary

ACCURAY INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $28.2M
Dividend Yield
Revenue Growth -12.3%
Op. Margin -6.6%
ROIC -14.5%
FCF / Share $-0.10
Trailing P/E
Price / Book 0.7x
FCF Yield
Debt / Equity 3.55
info Valuation on last close. End-of-day price, Sep 22, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$401.95M
↓ -12.3%
Net Income Profit after all expenses
$-49.19M
↓ -2992.0%
Operating Margin Operating profit as % of sales
-6.6%
↓ -484.8% 14th
FCF / Share Free cash flow per share
$-0.10
↓ -662.2%
Long-Term Debt Long-term obligations
$147.87M
↑ +8.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
12
Returns
6
Financial Health
23
Cash Quality
28

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 66 quarters